Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9621 posts found.

Latest news from Datamonitor

January 15, 2008 Research and Development

Competitive obtains license rights for breast cancer testCompetitive Technologies has signed a license and commercialization agreement for rights to the …
News

Animal toxicity test set to be scrapped

January 9, 2008 Research and Development

The pharmaceutical industry has made a major reduction in the number of rodents used in pre-clinical drug testing after an …
News

The Pharmafocus Interview: John Patterson

December 19, 2007 Research and Development, Sales and Marketing AstraZeneca, drug development, industry relations

John Patterson is an AstraZeneca man through-and-through, having spent nearly all his working life at the company. But over the …
Feature

Cervarix US approval delayed

December 19, 2007 Research and Development, Sales and Marketing

GlaxoSmithKline's cervical cancer vaccine Cervarix has suffered a setback in the US, where regulators have refused to approve it until …
News

Latest news from Datamonitor

December 18, 2007 Research and Development

BioMS's multiple sclerosis trial receives positive review from DSMBThe Data Safety Monitoring Board has reviewed data from BioMS Medical's ongoing …
News

Eisai signs $3.9bn biotech deal

December 14, 2007 Research and Development, Sales and Marketing Eisai

Japanese pharma company Eisai has acquired Minnesota-based biotech MGI Pharma for $3.9 billion, significantly boosting its oncology business.It is Eisai’s …
News

GSK boosts portfolio in cancer and anti-infectives

December 14, 2007 Research and Development

GSK has secured two new early-stage biotech licensing deals to boost its product pipeline.The UK-based group unveiled one partnership with …
News

Get ready for inspection

December 13, 2007 Research and Development MHRA, inspection, reg affairs

No one looks forward to receiving a letter from the MHRA (Medicines and Healthcare products Regulatory Agency) inspectorate announcing their …
Feature

Latest news from Datamonitor

December 10, 2007 Research and Development

Adventrx completes enrolment for breast cancer trialAdventrx Pharmaceuticals has completed patient enrolment in its Phase II clinical trial of CoFactor …
News

Safety first

December 10, 2007 Research and Development, Sales and Marketing clinical trials, drug development, drug safety

There is a tide of change in drug safety within the pharmaceutical industry.  Internal and external forces are pushing drug …
Feature

Sanofi and Regeneron sign antibody deal

November 30, 2007 Research and Development

Sanofi-Aventis has increased its stake in Regeneron and will collaborate with the US biotech company on new antibody research.The companies …
News

Latest news from Datamonitor

November 29, 2007 Research and Development

Medivir to initiate Phase IIa study of hepatitis CMedivir has announced that a Phase IIa study for its investigational hepatitis …
News

Pfizer buys immune system specialists Coley

November 22, 2007 Research and Development

Pfizer is to acquire a company developing new drugs that fight diseases by altering the immune system. The company is …
News

GSK pays $1.65 billion for cardiovascular specialists Reliant

November 22, 2007 Research and Development

News

Latest news from Datamonitor

November 20, 2007 Research and Development

Aeterna completes enrollment for Phase II trial of lung cancerAeterna Zentaris has completed patient recruitment for its European multi-center Phase …
News
The Gateway to Local Adoption Series

Latest content

SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer

May 22, 2026

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

May 21, 2026

NICE recommends sotatercept for pulmonary arterial hypertension

May 20, 2026

Vetter begins construction of new injectable medicines facility

May 20, 2026